Clinical Trials Browser

Phase 3 × Non-Muscle Invasive Bladder Neoplasms × Epirubicin × Clear all

NCT07424287 2026-02-20

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Phase 3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT04490993 2022-02-22

ACCRUE

Phase 3 Unknown

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

Phase 3 Unknown

Non-Muscle Invasive Bladder Neoplasms